Zogenix Inc. has acquired Brabant Pharma

Zogenix Acquires U.K.-Based Brabant Pharma | Fierce Biotech

SAN DIEGO, Calif., Oct. 27, 2014 (GLOBE NEWSWIRE) -- Zogenix, Inc. ... The acquisition includes worldwide development and commercialization rights ...

Zogenix Acquires Brabant Pharma in Up to $130M Deal

Zogenix Acquires Brabant Pharma in Up to $130M Deal ... Zogenix, a pharmaceutical company focused on the treatment of pain-related and central ...

Zogenix Acquires Brabant Pharma in $35M Deal - ProQuest

... has acquired Brabant Pharma, a privately-held U.K.-based pharmaceutical company for $20 million in cash and $15 million in stock, plus potential future ...

Zogenix Acquires U.K.-Based Brabant Pharma - GlobeNewswire

SAN DIEGO, Calif., Oct. 27, 2014 (GLOBE NEWSWIRE) -- Zogenix, Inc. ... The acquisition includes worldwide development and commercialization rights ...

Zogenix acquires U.K.-based Brabant Pharma | Drug Discovery News

... has acquired Brabant Pharma, a privately-held U.K.-based pharmaceutical company, for $20 million in cash and $15 million in stock plus potential future ...

Form 8-K - SEC.gov

On October 24, 2014, Zogenix Europe completed its acquisition of Brabant as described in Item 1.01, which description is incorporated herein by ...

Zogenix Inc. has acquired Brabant Pharma - Global M&A Partners

Zogenix Inc. USA Based - Pharmaceutical Company Zogenix Acquires UK Bases Brabant Pharma for up to $130m. logo. Advisor : Zeus ...

Zogenix Acquires Brabant Pharma Drug Lead For Dravet Syndrome

Pharmaceutical company Zogenix announced that it has acquired U.K.-based Brabant Pharma along with global rights to Brabafen...

Zogenix Acquires Brabant Pharma in $35M Deal - San Diego ...

... has acquired Brabant Pharma, a privately-held U.K.-based pharmaceutical company for $20 million in cash and $15 million in stock, plus potential future ...

Zogenix acquires UK-based Brabant Pharma for up to $130 million

A Denmark-headquartered company that currently has a pipeline of three independent endocrinology rare disease product candidates in clinical ...

Zogenix, Inc. Provides Business Update - BioSpace

Acquired Brabant Pharma on October 24, 2014 ... (Nasdaq:ZGNX) is a pharmaceutical company ... Zohydro® ER is a registered trademark of Zogenix, Inc.

Zogenix acquires Brabant pharma - 2014-10-27 - Crunchbase

zgnx-20201231 - SEC.gov

In October 2014, we acquired Brabant Pharma Limited (Brabant) in a ... acquisition of Brabant Pharma, a privately-held U.K.-based pharmaceutical company.

Brabant pharma - Crunchbase Company Profile & Funding

Brabant Pharma is in late-stage development of a treatment for Dravet Syndrome. Acquired by.

Dr. Stephen Farr Appointed As CEO Of Zogenix (ZGNX) To Lead ...

... acquisition of Brabant Pharma. The transformational acquisition ... (Nasdaq:ZGNX) is a pharmaceutical company committed to developing ...

UCB Completes Acquisition of Zogenix, Inc.

The pharmacy must be certified by enrolling in the FINTEPLA REMS and must only dispense to patients who are authorized to receive FINTEPLA.

Brabant Pharma Company Profile 2024 - PitchBook

Valuation & Funding. Deal Type 2. Merger/Acquisition. Date 27-Oct-2014. Amount ... Brabant Pharma was acquired by Zogenix. Data Transparency. Meet our data ...

Zogenix Provides Business Update - GlobeNewswire

Acquired Brabant Pharma on October 24, 2014 ... (Nasdaq:ZGNX) is a pharmaceutical company ... Zohydro® ER is a registered trademark of Zogenix, Inc.

News - Domain Associates

Zogenix acquires Brabant Pharma (a U.K.-based pharmaceutical company) and ... has been dosed in the U.S.. More ». Page 102 of 155 ‹ First < 100 101 102 ...

Zogenix, Inc. - Annual Reports

... subsidiary, acquired Brabant Pharma Limited, or Brabant, a privately-held company ... Acquisition of Brabant Pharma Limited. On October 24, 2014, Zogenix ...